Relationship Between Post Covid 19 Duration and Biomarkers: A Retrospective Study in Hospitalised Patients
DOI:
https://doi.org/10.37506/3wad3e44Keywords:
COVID-19, biomarkers, D-Dimer, Ferritin, C-Reactive Protein (CRP), Lactate dehydrogenase (LDH)Abstract
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), now known as coronavirus disease 2019 (COVID-19) were initially reported in Wuhan, China and rapidly spread throughout world in December 2019. The present retrospective study was postulated to assess the relationship between the post COVID 19 duration and biomarkers.
Methods: About 369 subjects diagnosed as COVID-19 infection confirmed by “Nasopharyngeal Reverse Transcription Polymerase Chain Reaction (RT-PCR) positive for SARS-CoV2” of all disease severity and admitted to Viveka Hospitals, Nagpur, Maharashtra, INDIA were included in the study. The laboratory investigations viz., D-Dimer, ferritin and C-reactive protein (CRP) and Lactate dehydrogenase (LDH) recorded at the time of admission, after 15th day and 30th day of discharged were retrieved from the hospital records. The relationship was computed using Paired t test and the confidence interval was set at 95%. The study was initiated after approval from the Institutional Ethics Committee of Viveka Hospitals, Nagpur, with Reg. No. ECR/1639/INST/MH/2021, Dated 20th Feb 2024.
Results: The mean D Dimer and ferritin values showed significant (p = 0.000) decrease after 15 days of discharge and CRP and LDH showed insignificant (p>0.05) increase and decrease respectively as compared to day of admission. After 30th days of discharge D Dimer increased significantly (p = 0.000) and ferritin and CRP decreased insignificantly (p>0.05).
Conclusion- It can be concluded from the study that COID19 biomarkers responds differently after 15th and 30th days of discharge. The suitable changes in medical protocols after 15th day and 30th days of discharge can reduce morbidity amongst the COVID 19 patients.
References
https://www.who.int/westernpacific/healthtopics/detail/coronavirus, Retrieved on December 10,2021.
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., Song, J., Wang, S., Chao, Y., Yang, Z., Xu, J., Zhou, X., Chen, D., Xiong, W., Xu, L., … Song, Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine.2020,180(7), 934–943.
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet (London, England).2020,395(10229), 1054–1062.
Garibaldi, B. T., Wang, K., Robinson, M. L., Zeger, S. L., Bandeen-Roche, K., Wang, M. C., Alexander, G. C., Gupta, A., Bollinger, R., & Xu, Y. Comparison of time to clinical improvement with vs without remdesivir treatment in hospitalized patients with COVID-19. JAMA Network Open, 4(3).2021, e213071.
Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using open safely. Nature. ;584(7821).2020, 430–436.
Cucinotta D, Vanelli M .WHO declares COVID-19 a pandemic. Acta Biomed .2020,91(1), 157–160.
Gao Y, Ding M, Dong X. et al. Risk factors for severe and critically ill COVID‐19 patients: A Review. Allergy. 2021,76(2),428–455.
CDC. 2019 Novel Coronavirus, Wuhan, China. CDC. Available at https://www.cdc.gov/coronavirus/2019-ncov/about/index.html. January 26, 2020
Tahir Huyut M, Huyut Z, İlkbahar F, Mertoğlu C. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictorsof COVID-19 mortality?IntImmunoPharmacol. 2022 ,105:108542
www.cleveland clinic.com,https://my.clevelandclinic.org/,2021,Dec 10
https://www.scienceimpactpub.com/journals/index.php/jei/article/view/481
Pasini, E., Corsetti, G., Romano, C., Scarabelli, T. M., Chen-Scarabelli, C., Saravolatz, L., & Dioguardi, F. S. (2021). Serum metabolic profile in patients with long-covid (pasc) syndrome: clinical implications. Frontiers in Medicine. (2021),8, 714426. https://doi.org/10.3389/fmed.2021.714426
Bivona, G., Agnello, L., & Ciaccio, M. Biomarkers for prognosis and treatment response in covid-19 patients. Annals of laboratory medicine.2021,41(6), 540–548. https://doi.org/10.3343/alm.2021.41.6.540
Yousaf, M., Abujaber, A. A., Almughalles, S., Thomas, M. M., & Hameed, M. A. (2024). Predictive value of D-dimer in assessing the risk of pulmonary embolism (PE) in Covid-19. Qatar Medical Journal.2024(2), 6. https://doi.org/10.5339/qmj.2024.qitc.6
Malik, F. T., Ishraquzzaman, M., Kalimuddin, M., Choudhury, S., Ahmed, N., Badiuzzaman, M., Ahmed, M. N., Banik, D., Huq, T. S., & Al Mamun, M. A. Clinical presentation, management and in-hospital outcome of healthcare personnel with covid-19 disease. Cureus.2020,12(8), e10004. https://doi.org/10.7759/cureus.10004
Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., et al. Epidemiologicalandclinical characteristics of 99 cases of 2019 novel coronavirus pneumonia inWuhan, China: a descriptive study. Lancet.395.2020,(10223),507–513.
Zhang, L., Yan, X., Fan, Q., Liu, H., Liu, X., Liu, Z., & Zhang, Z.D-Dimer levels on admission to predict in-hospital mortality in patients with covid-19. journal of thrombosis and haemostasis: JTH.2020, 18(6),1324–1329.
Ahmed, S., Ansar Ahmed, Z., Siddiqui, I., Haroon Rashid, N., Mansoor, M., & Jafri, L. Evaluation of serum ferritin for prediction of severity and mortality in COVID-19- a cross sectional study. Annals of Medicine and Surgery.2021, 63, 102163.
Liu, F., Li, L., Xu, M., Wu, J., Luo, D., Zhu, Y., Li, B., Song, X., & Zhou, X. Prognostic value of interleukin-6, c-reactive protein, and procalcitonin in patients with COVID-19. Journal of Clinical Virology: The Official Publication of The Pan American Society forClinical Virology.(2020),127, 104370.
Cao, P., Wu, Y., Wu, S., Wu, T., Zhang, Q., Zhang, R., Wang, Z., & Zhang, Y. Elevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia. Biomarkers: Biochemical Indicators of Exposure, Response, And Susceptibility to Chemicals.2021, 26(3), 207–212.
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., Manson, J. J., & HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London, England).2020, 395(10229), 1033–1034.
Bozkurt, F. T., Tercan, M., Patmano, G., BingolTanrıverdi, T., Demir, H. A., &Yurekli, U. F. Can Ferritin levels predict the severity of illness in patients with COVID-19? Cureus.2021, 13(1), e12832.
Gómez-Pastora, J., Weigand, M., Kim, J., Wu, X., Strayer, J., Palmer, A. F., Zborowski, M., Yazer, M., & Chalmers, J. J.Hyperferritinemiain critically ill covid-19 patients - is ferritin the product of inflammation or a pathogenic mediator? ClinicaChimica Acta; International Journal of Clinical Chemistry.(2020),509, 249–251.
Abdullah, A. J., Arif, A. T., Rahman, H. A., Sofihussein, K. Q., Hadi, J. M., Aziz, J. M. A., Tofiq, S. S., & Mustafa, A. M. Assessing serum c-reactive protein as a predictor of COVID-19 outcomes: a retrospective cross-sectional study. Annals of Medicine and Surgery.2023,85(7), 3359–3363.
Gebrecherkos T, Challa F, Tasew G, Gessesse Z, Kiros Y, Gebreegziabxier A, Abdulkader M, Desta AA, Atsbaha AH, Tollera G, Abrahim S, Urban BC, Schallig H, Rinke de Wit T, Wolday D. Prognostic value of c-reactive protein in sars-cov-2 infection: a simplified biomarker of COVID-19 severity in northern ethiopia. Infect Drug Resist. 2023,16:3019-3028
Ferraris, A. M., Giuntini, P., & Gaetani, G. F. Serum lactic dehydrogenase as a prognostic tool for non-hodgkin lymphomas. Blood.1979,54(4), 928–932.
Xiang, J., Zhou, L., He, Y., & Wu, S. LDH-A Inhibitors as remedies to enhance the anticancer effects of parp inhibitors in ovarian cancer cells. Aging.2021, 13(24), 25920–25930.
Li, C., Ye, J., Chen, Q., Hu, W., Wang, L., Fan, Y., Lu, Z., Chen, J., Chen, Z., Chen, S., Tong, J., Xiao, W., Mei, J., & Lu, H.Elevated lactate dehydrogenase (ldh) level as an independent risk factor for the severity and mortality of COVID-19. Aging. 2020,12(15), 15670–15681.
Mao Manyun , Dian Yating , Sun Yuming , Chen Wangqing , Zhu Wu , Deng Guangtong.Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with azvudine.Frontiers in Cellular And Infection Microbiology.2023, 13.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pradnya Manish Bagalkote, Rekha Sharma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.